1-6 of 6
Huijuan Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Three-Year Follow-up on Efficacy and Safety Results from Phase 1 Lummicar Study 1 of Zevorcabtagene Autoleucel in Chinese Patients with Relapsed or Refractory Multiple Myeloma

Chengcheng Fu, Wenming Chen, Zhen Cai, Lingzhi Yan, Huijuan Wang, Jingjing Shang, Yin Wu, Shuang Yan, Wen Gao, Xiaolan Shi, Xiaoyan Han, Fang Tang, Gaofeng Zheng, Yanling Wen, Xingxing Meng, Wei Zheng, Huamao Wang, Zonghai Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 4845.
https://doi.org/10.1182/blood-2023-184373
Published: 2023
Journal Articles

The Value of PET/CT Combined with Next-Generation Flowcytometry in Minimal Residual Disease Detection and Prognostic Evaluation of Multiple Myeloma

Jianhua Du, Miao Chen, Li Huo, Wenjia Zhu, Huijuan Wang, Yun Leng, Shuangjiao Liu, Junling Zhuang
Journal: Blood
Blood (2022) 140 (Supplement 1): 7214.
https://doi.org/10.1182/blood-2022-165326
Published: 2022
Journal Articles

Sustainable Efficacy and Safety Results from Lummicar Study 1: A Phase 1/2 Study of Fully Human B-Cell Maturation Antigen-Specific CAR T Cells (CT053) in Chinese Subjects with Relapsed and/or Refractory Multiple Myeloma

Wenming Chen, Chengcheng Fu, Zhen Cai, Zonghai Li, Huijuan Wang, Lingzhi Yan, Yin Wu, Xiaolan Shi, Wen Gao, Shuang Yan, Wei Wang, Xiaoyan Han, Gaofeng Zheng, Yanling Wen, Jun Xiao, Huamao Wang, Xiaole Tang
Journal: Blood
Blood (2021) 138 (Supplement 1): 2821.
https://doi.org/10.1182/blood-2021-150124
Published: 2021
Journal Articles

Integrated Analysis of B-Cell Maturation Antigen-Specific CAR T Cells (CT053) in Relapsed and Refractory Multiple Myeloma Subjects By High-Risk Factors

Chengcheng Fu, Songfu Jiang, Jie Jin, Wenming Chen, Siguo Hao, Zhen Cai, Zonghai LI, Lingzhi Yan, Kang Yu, Min Yang, Huijuan Wang, Wenhao Zhang, Xiaoyan Han, Wei Wang, Hongxia Zhao
Journal: Blood
Blood (2021) 138 (Supplement 1): 1751.
https://doi.org/10.1182/blood-2021-151935
Published: 2021
Journal Articles

Results from Lummicar-1: A Phase 1 Study of Fully Human B-Cell Maturation Antigen-Specific CAR T Cells (CT053) in Chinese Subjects with Relapsed and/or Refractory Multiple Myeloma

Wenming Chen, MD PhD, Chengcheng Fu, MD PhD, Zhen Cai, MD PhD, Zonghai Li, MD PhD, Huijuan Wang, MD PhD, Lingzhi Yan, MD PhD, Yin Wu, MD PhD, Xiaolan Shi, MD PhD, Wen Gao, MD, Shuang Yan, MD, Wei Wang, MDPhD, Xiaoyan Han, MD PhD, Gaofeng Zheng, MD PhD, Yanling Wen, MD, Jun Xiao, MD, Huamao Wang, PhD, Hong Ma, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 49–50.
https://doi.org/10.1182/blood-2020-140727
Published: 2020
Journal Articles

T(4; 14) Is Not a Poor Prognostic Factor for Newly Diagnosed Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation in New Drug Era

Chuanying Geng, MD, Guangzhong Yang, Wen Gao, MD, Huijuan Wang, Yanchen Li, Yin WU, Huixing Zhou, MD, Zhiyao Zhang, MD, Yuan Jian, Wenming Chen, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 30.
https://doi.org/10.1182/blood-2020-140268
Published: 2020